139 related articles for article (PubMed ID: 18684245)
21. Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study.
Malfertheiner P; Nocon M; Vieth M; Stolte M; Jaspersen D; Koelz HR; Labenz J; Leodolter A; Lind T; Richter K; Willich SN
Aliment Pharmacol Ther; 2012 Jan; 35(1):154-64. PubMed ID: 22070159
[TBL] [Abstract][Full Text] [Related]
22. Intra-oesophageal acid suppression in complicated gastro-oesophageal reflux disease: esomeprazole versus lansoprazole.
Frazzoni M; Manno M; De Micheli E; Savarino V
Dig Liver Dis; 2006 Feb; 38(2):85-90. PubMed ID: 16289976
[TBL] [Abstract][Full Text] [Related]
23. Impact of dialysis on gastroesophageal reflux, dyspepsia, and proton pump inhibitor treatment in patients with chronic renal failure.
Strid H; Fjell A; Simrén M; Björnsson ES
Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):137-42. PubMed ID: 19212202
[TBL] [Abstract][Full Text] [Related]
24. Effect of proton pump inhibition on the gastric volume: assessed by magnetic resonance imaging.
Babaei A; Bhargava V; Aalam S; Scadeng M; Mittal RK
Aliment Pharmacol Ther; 2009 Apr; 29(8):863-70. PubMed ID: 19170660
[TBL] [Abstract][Full Text] [Related]
25. Review article: is stringent control of gastric pH useful and practical in GERD?
Kahrilas PJ
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():89-94; discussion 95-6. PubMed ID: 15456470
[TBL] [Abstract][Full Text] [Related]
26. Esomeprazole relieves upper gastrointestinal symptoms in high-risk and average-risk NSAID users in daily clinical practice: results from an open-label study.
Tielemans MM; van Oijen MG; Mulder CJ; Vos KJ; Lems WF
Eur J Gastroenterol Hepatol; 2012 Mar; 24(3):281-7. PubMed ID: 22246328
[TBL] [Abstract][Full Text] [Related]
27. Clinical trial: esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbances.
Johnson D; Crawley JA; Hwang C; Brown K
Aliment Pharmacol Ther; 2010 Jul; 32(2):182-90. PubMed ID: 20456306
[TBL] [Abstract][Full Text] [Related]
28. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.
Aanen MC; Weusten BL; Numans ME; de Wit NJ; Samsom M; Smout AJ
J Clin Gastroenterol; 2008; 42(5):441-7. PubMed ID: 18344896
[TBL] [Abstract][Full Text] [Related]
29. Water load test before and after PPI therapy in patients with gastro-oesophageal reflux disease.
Battaglia E; Grassini M; Navino M; Niola P; Verna C; Mazzocchi A; Clerici C; Morelli A; Bassotti G
Dig Liver Dis; 2007 Dec; 39(12):1052-6. PubMed ID: 17913607
[TBL] [Abstract][Full Text] [Related]
30. Race affects healing of erosive oesophagitis in patients treated with proton pump inhibitors.
Sharma P; Johnson DA; Monyak JT; Illueca M
Aliment Pharmacol Ther; 2011 Aug; 34(4):487-93. PubMed ID: 21682754
[TBL] [Abstract][Full Text] [Related]
31. Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy.
Frazzoni M; Savarino E; Manno M; Melotti G; Mirante VG; Mussetto A; Bertani H; Manta R; Conigliaro R
Aliment Pharmacol Ther; 2009 Sep; 30(5):508-15. PubMed ID: 19519732
[TBL] [Abstract][Full Text] [Related]
32. The gain in quality-adjusted life months by switching to esomeprazole in those with continued reflux symptoms in primary care: EncomPASS--a cluster-randomized trial.
Moayyedi P; Armstrong D; Hunt RH; Lei Y; Bukoski M; White RJ
Am J Gastroenterol; 2010 Nov; 105(11):2341-6. PubMed ID: 20842110
[TBL] [Abstract][Full Text] [Related]
33. Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study.
Dent J; Vakil N; Jones R; Bytzer P; Schöning U; Halling K; Junghard O; Lind T
Gut; 2010 Jun; 59(6):714-21. PubMed ID: 20551454
[TBL] [Abstract][Full Text] [Related]
34. Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment.
Poh CH; Gasiorowska A; Navarro-Rodriguez T; Willis MR; Hargadon D; Noelck N; Mohler J; Wendel CS; Fass R
Gastrointest Endosc; 2010 Jan; 71(1):28-34. PubMed ID: 19922918
[TBL] [Abstract][Full Text] [Related]
35. Transmucosal gastric leak induced by proton pump inhibitors.
Murray LJ; Gabello M; Rudolph DS; Farrell CP; Morgan M; Martin AP; Underwood JC; Valenzano MC; Mullin JM
Dig Dis Sci; 2009 Jul; 54(7):1408-17. PubMed ID: 19015985
[TBL] [Abstract][Full Text] [Related]
36. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response.
Park W; Hicks DM; Khandwala F; Richter JE; Abelson TI; Milstein C; Vaezi MF
Laryngoscope; 2005 Jul; 115(7):1230-8. PubMed ID: 15995512
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
Higginbotham TW
Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
[TBL] [Abstract][Full Text] [Related]
38. Proton pump inhibitors: actions and reactions.
Mullin JM; Gabello M; Murray LJ; Farrell CP; Bellows J; Wolov KR; Kearney KR; Rudolph D; Thornton JJ
Drug Discov Today; 2009 Jul; 14(13-14):647-60. PubMed ID: 19443264
[TBL] [Abstract][Full Text] [Related]
39. High-dose esomeprazole for treatment of symptomatic refractory gastroesophageal reflux disease--a prospective pH-metry/impedance-controlled study.
Bajbouj M; Becker V; Phillip V; Wilhelm D; Schmid RM; Meining A
Digestion; 2009; 80(2):112-8. PubMed ID: 19641320
[TBL] [Abstract][Full Text] [Related]
40. Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors.
Raghunath AS; Hungin AP; Mason J; Jackson W
Aliment Pharmacol Ther; 2009 Feb; 29(4):431-9. PubMed ID: 19035981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
